CytoMed Therapeutics Limited (GDTC) Financials
GDTC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 6.2 million | 879392 |
| June 30, 2025 | 6.6 million | 892509 |
| March 31, 2025 | 6.2 million | 844704 |
| Dec. 31, 2024 | 7.4 million | 749763 |
GDTC Free Cash Flow and Stock based compensation
No data available :(
GDTC Net Income
No data available :(
GDTC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 1.6 million | 286570 | 56791 |
| June 30, 2025 | 2.2 million | 292953 | 62001 |
| March 31, 2025 | 2.1 million | 277262 | 58680 |
| Dec. 31, 2024 | 3.6 million | 288721 | 22910 |
GDTC Shares Outstanding
GDTC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 231747 | 817886 | 579178 | - |
| June 30, 2025 | 262729 | 457110 | 151820 | - |
| March 31, 2025 | 129437 | 432626 | 143688 | 4128 |
| Dec. 31, 2024 | 179434 | 342355 | 123669 | 5543 |
GDTC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 130625 | 562801 |
| June 30, 2025 | 105705 | 7326 |
| March 31, 2025 | 100043 | 6934 |
| Dec. 31, 2024 | 52415 | 10558 |
GDTC
Price: $1.03
52 week price:
Earnings Per Share: -0.27 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 10.3 million